findmyKOL

Fareeha Siddiqui, MD

Basic profile

University of California San Diego

ORCIDNone on fileNPI
RegionSan Diego, CA · WestSpecialtyHematology / OncologyFocusOncology
Last active 2021findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2021Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Fareeha Siddiqui is an Oncology physician affiliated with University of California San Diego. OpenAlex indexes 7 publications with 293 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
7publications

Distinct works indexed by OpenAlex.

293citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    33.5%
    Statin11.4%
    Atorvastatin Calcium63%Rosuvastatin Calcium22%Simvastatin9%Pravastatin Sodium5%Lovastatin1%
    Part D<11 patients
    Beta blocker4.1%
    Metoprolol Tartrate36%Carvedilol23%Metoprolol Succinate20%Atenolol16%Nebivolol Hcl4%Labetalol Hcl2%
    Part D<11 patients

    + 18 more classes in this area

  • Metabolism & gastrointestinal

    29.5%
    Proton pump inhibitor10.3%
    Omeprazole52%Pantoprazole Sodium22%Omeprazole-Sodium Bicarbonate11%Dexlansoprazole Dr8%Esomeprazole Magnesium6%Lansoprazole2%
    Part D<11 patients
    Biguanide (metformin)5.8%
    Metformin Hcl94%Metformin Er Gastric4%Metformin Hcl Er3%
    Part D<11 patients

    + 18 more classes in this area

  • Nervous system

    10.1%
    Atypical Antipsychotic2.1%
    Aripiprazole47%Quetiapine Fumarate29%Risperidone9%Olanzapine6%Lurasidone Hcl5%Ziprasidone Hcl5%
    Part D<11 patients
    SSRI1.9%
    Escitalopram Oxalate42%Sertraline Hcl26%Trazodone Hcl11%Citalopram Hbr11%Paroxetine Hcl10%
    Part D<11 patients

    + 15 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”